The Altered Hemorheologic Parameters in Thromboangiitis Obliterans: A New Insight

Clinical and Applied Thrombosis/Hemostasis

Volumn 10, Issue 1, 2004, Pages 45-50

  Bozkurt, A Kursat ^a   Koksal, Cengiz ^b,c   Ercan, Meltem ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Sureyyapasa Thoracic and Cardiovascular Disease Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

Blood viscosity; Erythrocyte deformability; Peripheral vascular disease; Rheology; Thromboangiitis obliterans

Indexed keywords

FIBRINOGEN;

ADULT; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; BUERGER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; ERYTHROCYTE DEFORMABILITY; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HUMAN; LIMB ISCHEMIA; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PLASMA VISCOSITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHEAR RATE;

EID: 2142823659     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960401000107     Document Type: Article

References (30)

1. Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 2000;343(12):864.
2. Shionoya S. Surgical treatment. In: Shinoya S, ed. Buerger's Disease. Pathology, Diagnosis and Treatment. Nagoya/Japan: The University of Nagoya Press; 1990:212.
3. Kobayashi M, Ito M, Nakagawa A, et al. Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans). J Vasc Surg 1999;29:451.
4. Angelkort B, Amann B, Lawall H. Hemorheology and hemostasis in vascular disease. A pathophysiological review. Clin Hemorheol Microcirc 2002;26:145.
5. Lowe GD, Fowkes FG, Dawes J, et al. Blood viscosity, fibrinogen and activation of coagulation and leucocytes in peripheral arterial disease and the normal disease and the normal population in the Edinburgh Artery Study. Circulation 1993;87:1915.
6. Dormandy JA, Hoare E, Khattib AH, et al. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. BMJ 1973; 4(5892):581.
7. Violi F, Criqui M, Longani A, the ADEP Group. Relation between risk factors and cardiovascular complications in patients with peripheral arterial disease: Results from the ADEP study. Atherosclerosis 1996;120:25.
8. Intravenous pentoxyflline for the treatment of chronic critical limb ischemia: The European Study Group. Eur J Vasc Endovasc Surg 1995;9(4):426.
9. Frampton JE, Brogden RN. Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders. Drugs Aging 1995;7(6):480.
10. International Committee for standardization in hematology expert panel on blood rheology (1986). Guidelines for measurement of blood viscosity and erythrocyte deformability. Clin Hemorheol Microcirc 1986;6:539.
11. Wells Jr RE, Denton D, Melvill E. Measurement of viscosity of biologic fluids by cone-plate viscometer. J Lab Clin Med 1961;57:646.
12. Harkness J. A new method for the measurement of plasma viscosity. Lancet 1963;2:280.
13. Matrai A, Wittingham RB, Ernst E. A simple method of estimating whole blood viscosity at standardized hemotocrit. Clin Hemorheol Microcirc 1987;7:261.
14. Dintenfass L. Red cell rigidity, Tk and filtration. Clin Hemorheol 1985;5:241.
15. Usami S. Development of hemorheology: Perspective in instrumentation development. Clin Hemorheol Microcirc 2000;23:77.
16. Sasaki S, Sakuma M, Yasuda K. Current status of thromboangiitis obiterans (Buerger's disease) in Japan. Int J Cardiol 2000;75:S175.
17. Shionoya S. Buerger's disease (thromboangiitis obliterans). In: Rutherford RB (ed). Vascular Surgery, vol. 1. Philadelphia: WB Saunders, 1989:207.
18. Sayin A, Bozkurt AK, Tuzun H, et al. Surgical treatment of Buerger's disease: Experience with 216 patients. Cardiovasc Surg 1993;1:377.
19. Fiessinger JN, Schafer M. Trial of iloprost versus aspirin treatment for critical limb ischemia of thromboangiitisi obliterans: The TAO study. Lancet 1990;335:555.
20. Smith FB, Lowe GD, Lee AJ, et al. Smoking, hemorheologic factors, and progression of peripheral arterial disease in patients with claudication. J Vasc Surg 1998; 28:129.
21. Criqui MH, Browner D, Franek A, et al. Peripheral arterial disease in large vessels is epidemiological distinct from small vessel disease. Am J Epidemiol 1989;129(6):1110.
22. Banerjee R, Nageshwari K, Puniyani RR. The diagnostic relevance of red blood cell rigidity. Clin Hemorheol Microcirc 1998;19:21.
23. Soldana C, Songento I, Momteiro J. Impairment of the erythrocyte membrane fluidity in survivors of acute myocardial infarction: A prospective study. Clin Hemorheol Microcirc 1999;20:111.
24. Szendro G, Golcman L, Cristal N. Study of the factors affecting blood viscosity in patients with thromboangiitis obliterans. J Vasc Surg 1988;7:756.
25. Koksal C, Ercan M, Bozkurt AK. Hemorrheologic variables in critical limb ischemia. Int Angiol 2002;21(4):355.
26. Mokken FC, Kedaria M, Henny CP, et al. The clinical importance of erythrocytes deformability, a hemorheological parameter. Am Hematol 1992;64:113.
27. Lee AJ, Fowkes FG, Rattray A, et al. Haemostatic and theological factors in intermittant daudication: The influence of smoking and extent of arterial disease. Br J Haematol 1996;92:226.
28. Lowe GD, Drummond MM, Forbes CD, et al. The effects of age and cigarette-smoking on blood and plasma viscosity in men. Scot Med J 1980;25:13.
29. Salbas K. Effect of acute smoking on red blood cell deformability in healthy young and elderly non-smokers and effect of verapamil on age and acute-smoking-induced change in red blood cell deformability. Scand J Clin Lab Invest 1994;54:411.
30. Haustein KO, Krause J, Haustein H, et al. Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology. J Int Med 2002;252:130.